US4942184A
(en)
*
|
1988-03-07 |
1990-07-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water soluble, antineoplastic derivatives of taxol
|
FR2629819B1
(fr)
*
|
1988-04-06 |
1990-11-16 |
Rhone Poulenc Sante |
Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
|
USRE34277E
(en)
*
|
1988-04-06 |
1993-06-08 |
Centre National De La Recherche Scientifique |
Process for preparing taxol
|
FR2629818B1
(fr)
*
|
1988-04-06 |
1990-11-16 |
Centre Nat Rech Scient |
Procede de preparation du taxol
|
US4960790A
(en)
*
|
1989-03-09 |
1990-10-02 |
University Of Kansas |
Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
|
MY110249A
(en)
*
|
1989-05-31 |
1998-03-31 |
Univ Florida State |
Method for preparation of taxol using beta lactam
|
US5175315A
(en)
*
|
1989-05-31 |
1992-12-29 |
Florida State University |
Method for preparation of taxol using β-lactam
|
US5136060A
(en)
*
|
1989-11-14 |
1992-08-04 |
Florida State University |
Method for preparation of taxol using an oxazinone
|
US5015744A
(en)
*
|
1989-11-14 |
1991-05-14 |
Florida State University |
Method for preparation of taxol using an oxazinone
|
FR2658513B1
(fr)
*
|
1990-02-21 |
1994-02-04 |
Rhone Poulenc Sante |
Procede de preparation de l'acide cis-beta-phenylglycidique-(2r,3r).
|
US5059699A
(en)
*
|
1990-08-28 |
1991-10-22 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble derivatives of taxol
|
FR2679557B1
(fr)
*
|
1991-07-25 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Procede de preparation de derives du taxane, nouveaux derives obtenus et compositions pharmaceutiques qui les contiennent.
|
MX9102128A
(es)
*
|
1990-11-23 |
1992-07-08 |
Rhone Poulenc Rorer Sa |
Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
|
EP0580759B1
(en)
*
|
1991-04-19 |
1999-05-26 |
The University Of Mississippi |
Methods and compositions for isolating taxanes
|
CA2072400C
(en)
|
1991-07-05 |
2003-08-19 |
Jayaprakash B. Nair |
Supercritical extraction of taxanes
|
FR2679558B1
(fr)
*
|
1991-07-25 |
1993-09-24 |
Rhone Poulenc Rorer Sa |
Procede de preparation de la cinnamoyl-13alpha baccatine iii ou desacetyl-10 baccatine iii.
|
US6005138A
(en)
*
|
1991-09-23 |
1999-12-21 |
Florida State University |
Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
|
US5430160A
(en)
*
|
1991-09-23 |
1995-07-04 |
Florida State University |
Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
|
US5710287A
(en)
*
|
1991-09-23 |
1998-01-20 |
Florida State University |
Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
|
US5739362A
(en)
*
|
1991-09-23 |
1998-04-14 |
Florida State University |
Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
|
US7074945B2
(en)
*
|
1991-09-23 |
2006-07-11 |
Florida State University |
Metal alkoxide taxane derivatives
|
US5654447A
(en)
*
|
1991-09-23 |
1997-08-05 |
Florida State University |
Process for the preparation of 10-desacetoxybaccatin III
|
US5227400A
(en)
*
|
1991-09-23 |
1993-07-13 |
Florida State University |
Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
|
US5998656A
(en)
*
|
1991-09-23 |
1999-12-07 |
Florida State University |
C10 tricyclic taxanes
|
US5721268A
(en)
|
1991-09-23 |
1998-02-24 |
Florida State University |
C7 taxane derivatives and pharmaceutical compositions containing them
|
US5283253A
(en)
*
|
1991-09-23 |
1994-02-01 |
Florida State University |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
|
US5229526A
(en)
*
|
1991-09-23 |
1993-07-20 |
Florida State University |
Metal alkoxides
|
US5350866A
(en)
*
|
1991-09-23 |
1994-09-27 |
Bristol-Myers Squibb Company |
10-desacetoxytaxol derivatives
|
US5243045A
(en)
*
|
1991-09-23 |
1993-09-07 |
Florida State University |
Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
|
US6335362B1
(en)
|
1991-09-23 |
2002-01-01 |
Florida State University |
Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
|
US5489601A
(en)
*
|
1991-09-23 |
1996-02-06 |
Florida State University |
Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
|
US5714513A
(en)
*
|
1991-09-23 |
1998-02-03 |
Florida State University |
C10 taxane derivatives and pharmaceutical compositions
|
US6794523B2
(en)
|
1991-09-23 |
2004-09-21 |
Florida State University |
Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
|
US5284865A
(en)
*
|
1991-09-23 |
1994-02-08 |
Holton Robert A |
Cyclohexyl substituted taxanes and pharmaceutical compositions containing them
|
US5250683A
(en)
*
|
1991-09-23 |
1993-10-05 |
Florida State University |
Certain substituted taxanes and pharmaceutical compositions containing them
|
US5274124A
(en)
*
|
1991-09-23 |
1993-12-28 |
Florida State University |
Metal alkoxides
|
US5728850A
(en)
*
|
1991-09-23 |
1998-03-17 |
Florida State University |
Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
|
US6018073A
(en)
*
|
1991-09-23 |
2000-01-25 |
Florida State University |
Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
|
US6495704B1
(en)
|
1991-09-23 |
2002-12-17 |
Florida State University |
9-desoxotaxanes and process for the preparation of 9-desoxotaxanes
|
ATE195973T1
(de)
*
|
1992-01-15 |
2000-09-15 |
Squibb & Sons Inc |
Enzymatische verfahren zur resolution von enantiomeren-mischungen nützlich wie zwischenprodukte zur herstellung von taxanen
|
US5294737A
(en)
*
|
1992-02-27 |
1994-03-15 |
The Research Foundation State University Of New York |
Process for the production of chiral hydroxy-β-lactams and hydroxyamino acids derived therefrom
|
US5445809A
(en)
*
|
1992-03-03 |
1995-08-29 |
Research And Development Institute At Montana State University |
Production of taxol from the yew tree
|
US5451392A
(en)
*
|
1992-03-03 |
1995-09-19 |
The Research And Development Institute At Montana State University |
Production of taxol
|
US5200534A
(en)
*
|
1992-03-13 |
1993-04-06 |
University Of Florida |
Process for the preparation of taxol and 10-deacetyltaxol
|
US5254703A
(en)
*
|
1992-04-06 |
1993-10-19 |
Florida State University |
Semi-synthesis of taxane derivatives using metal alkoxides and oxazinones
|
JPH07505887A
(ja)
*
|
1992-04-17 |
1995-06-29 |
アボツト・ラボラトリーズ |
タキソール誘導体
|
US5364947A
(en)
*
|
1992-07-02 |
1994-11-15 |
Hauser Chemical Research, Inc. |
Process for separating cephalomannine from taxol using ozone and water-soluble hydrazines or hydrazides
|
US5470866A
(en)
*
|
1992-08-18 |
1995-11-28 |
Virginia Polytechnic Institute And State University |
Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
|
US5319112A
(en)
*
|
1992-08-18 |
1994-06-07 |
Virgnia Tech Intellectual Properties, Inc. |
Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
|
FR2696462B1
(fr)
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé d'obtention de la désacétyl-10 baccatine III.
|
US5411984A
(en)
*
|
1992-10-16 |
1995-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble analogs and prodrugs of taxol
|
FR2697752B1
(fr)
*
|
1992-11-10 |
1995-04-14 |
Rhone Poulenc Rorer Sa |
Compositions antitumorales contenant des dérivés du taxane.
|
US5420337A
(en)
*
|
1992-11-12 |
1995-05-30 |
E. R. Squibb & Sons, Inc. |
Enzymatic reduction method for the preparation of compounds useful for preparing taxanes
|
US5631278A
(en)
*
|
1992-12-02 |
1997-05-20 |
Thomas Jefferson University |
Methods of killing protozoal parasites
|
US5356927A
(en)
*
|
1992-12-02 |
1994-10-18 |
Thomas Jefferson University |
Methods of treating plasmodium and babesia parasitic infections
|
FR2698871B1
(fr)
|
1992-12-09 |
1995-02-24 |
Rhone Poulenc Rorer Sa |
Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
MX9307777A
(es)
|
1992-12-15 |
1994-07-29 |
Upjohn Co |
7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
|
US5973160A
(en)
*
|
1992-12-23 |
1999-10-26 |
Poss; Michael A. |
Methods for the preparation of novel sidechain-bearing taxanes
|
US5688517A
(en)
*
|
1993-01-29 |
1997-11-18 |
Napro Biotherapeutics, Inc. |
Method for assessing sensitivity of tumor cells to cephalomannine and 10-deacetyltaxol
|
US5948919A
(en)
*
|
1993-02-05 |
1999-09-07 |
Napro Biotherapeutics, Inc. |
Paclitaxel synthesis from precursor compounds and methods of producing the same
|
NZ262030A
(en)
*
|
1993-02-05 |
1997-10-24 |
Bryn Mawr College |
Process for preparing a taxol intermediate
|
US6710191B2
(en)
|
1993-03-05 |
2004-03-23 |
Florida State University |
9β-hydroxytetracyclic taxanes
|
ES2193154T3
(es)
*
|
1993-03-05 |
2003-11-01 |
Univ Florida State |
Procedimiento para la preparacion de 9-desoxotaxanos.
|
US5703247A
(en)
*
|
1993-03-11 |
1997-12-30 |
Virginia Tech Intellectual Properties, Inc. |
2-Debenzoyl-2-acyl taxol derivatives and methods for making same
|
TW467896B
(en)
|
1993-03-19 |
2001-12-11 |
Bristol Myers Squibb Co |
Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
|
US5336684A
(en)
*
|
1993-04-26 |
1994-08-09 |
Hauser Chemical Research, Inc. |
Oxidation products of cephalomannine
|
PT982302E
(pt)
*
|
1993-06-11 |
2004-07-30 |
Upjohn Co |
Utilizacao de delta 6,7-taxois antineoplasicos e composicoes farmaceuticas que os contem
|
US5516676A
(en)
*
|
1993-06-15 |
1996-05-14 |
Bristol-Myers Squibb Company |
Preparation of C-13 hydroxyl-bearing taxanes using nocardioides or a hydrolase isolated therefrom
|
US5523219A
(en)
*
|
1993-06-15 |
1996-06-04 |
Bristol-Myers Squibb Company |
Enzymatic hydrolysis method for the preparation of C-10 hydroxyl-bearing taxanes and enzymatic esterification method for the preparation of C-10 acyloxy-bearing
|
IL109926A
(en)
*
|
1993-06-15 |
2000-02-29 |
Bristol Myers Squibb Co |
Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
|
US5405972A
(en)
*
|
1993-07-20 |
1995-04-11 |
Florida State University |
Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
|
US6005120A
(en)
|
1993-07-20 |
1999-12-21 |
Florida State University |
Tricyclic and tetracyclic taxanes
|
US6441026B1
(en)
|
1993-11-08 |
2002-08-27 |
Aventis Pharma S.A. |
Antitumor compositions containing taxane derivatives
|
US5415869A
(en)
*
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
FR2714053B1
(fr)
*
|
1993-12-22 |
1996-03-08 |
Pf Medicament |
Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
|
IL127597A
(en)
*
|
1994-01-28 |
2003-07-31 |
Upjohn Co |
Iso-taxol analogs
|
US5449790A
(en)
*
|
1994-04-06 |
1995-09-12 |
Hauser Chemical Research, Inc. |
Preparation of 10-deacetylbaccatin III and 7-protected-10-deacetylbaccatin III derivatives from 10-deacetyl taxol A, 10-deacetyl taxol B, and 10-deacetyl taxol C
|
US5508447A
(en)
*
|
1994-05-24 |
1996-04-16 |
Board Of Regents, The University Of Texas System |
Short synthetic route to taxol and taxol derivatives
|
US5602272A
(en)
*
|
1994-06-21 |
1997-02-11 |
Bristol-Myers Squibb Company |
Reduction and resolution methods for the preparation of compounds useful as intemediates for preparing taxanes
|
US5677470A
(en)
|
1994-06-28 |
1997-10-14 |
Tanabe Seiyaku Co., Ltd. |
Baccatin derivatives and processes for preparing the same
|
US5629433A
(en)
*
|
1994-07-18 |
1997-05-13 |
Hauser, Inc. |
Selective process for the deacylation and deacetylation of taxol and taxanes
|
US5679807A
(en)
*
|
1995-01-30 |
1997-10-21 |
Hauser, Inc. |
Preparation of taxol and docetaxel through primary amines
|
DE19506885A1
(de)
*
|
1995-02-17 |
1996-08-22 |
Schering Ag |
Neue Borneolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
DE19509697A1
(de)
*
|
1995-03-08 |
1996-09-12 |
Schering Ag |
Neue Borneole, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
CA2170661A1
(en)
|
1995-03-22 |
1996-09-23 |
John K. Thottathil |
Novel methods for the preparation of taxanes using oaxzolidine intermediates
|
DE19513040A1
(de)
*
|
1995-03-29 |
1996-10-02 |
Schering Ag |
Neue Borneolester, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
AU716005B2
(en)
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
US5675025A
(en)
*
|
1995-06-07 |
1997-10-07 |
Napro Biotherapeutics, Inc. |
Paclitaxel synthesis from precursor compounds and methods of producing the same
|
US5760251A
(en)
*
|
1995-08-11 |
1998-06-02 |
Sepracor, Inc. |
Taxol process and compounds
|
FR2743074B1
(fr)
*
|
1995-12-27 |
1998-03-27 |
Seripharm |
Procede de protection selective des derives de la baccatine et son utilisation dans la synthese des taxanes
|
US5688977A
(en)
*
|
1996-02-29 |
1997-11-18 |
Napro Biotherapeutics, Inc. |
Method for docetaxel synthesis
|
CN1221412A
(zh)
*
|
1996-05-06 |
1999-06-30 |
佛罗里达州立大学 |
1-脱氧浆果赤霉素ⅲ,1-脱氧紫杉醇和1-脱氧紫杉醇类似物及其制备方法
|
EP0912504B1
(en)
*
|
1996-05-08 |
2002-09-11 |
PHARMACIA & UPJOHN COMPANY |
Oxazolidine ester
|
US5919815A
(en)
*
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
US6576636B2
(en)
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
ATE196844T1
(de)
*
|
1996-05-22 |
2000-10-15 |
Protarga Inc |
Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
|
US5750737A
(en)
*
|
1996-09-25 |
1998-05-12 |
Sisti; Nicholas J. |
Method for paclitaxel synthesis
|
BR9808697A
(pt)
|
1997-04-28 |
2000-07-11 |
Rhone Poulenc Rorer Sa |
Processo para inibir o crescimento de um tumor, vetor de adenovìrus defeituoso, vetor de vìrus, uso do mesmo, e, composição farmacêutica
|
US7288665B1
(en)
|
1997-08-18 |
2007-10-30 |
Florida State University |
Process for selective derivatization of taxanes
|
WO1999008986A1
(en)
*
|
1997-08-21 |
1999-02-25 |
Florida State University |
Method for the synthesis of taxanes
|
JP4153660B2
(ja)
|
1997-10-08 |
2008-09-24 |
株式会社横浜国際バイオ研究所 |
タキソイド誘導体およびその製造方法
|
US5917062A
(en)
*
|
1997-11-21 |
1999-06-29 |
Indena S.P.A |
Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
|
US20040234472A1
(en)
|
2001-04-20 |
2004-11-25 |
Jackson John K. |
Micellar drug delivery systems for hydrophobic drugs
|
IN192059B
(es)
*
|
1999-02-12 |
2004-02-14 |
Council Scient Ind Res |
|
US7235583B1
(en)
*
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
MXPA01011046A
(es)
*
|
1999-05-17 |
2002-07-22 |
Squibb Bristol Myers Co |
Novedosas condiciones de reaccion para la escicion de teres de sililo en la preparacion de paclitaxel (taxol, marca registrada) y analogos de paclitaxel.
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
US6452024B1
(en)
|
2000-02-22 |
2002-09-17 |
Chaichem Pharmaceuticals International |
Process for extraction and purification of paclitaxel from natural sources
|
JP2003525239A
(ja)
*
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
タキサン化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
|
US6638742B1
(en)
|
2000-07-07 |
2003-10-28 |
University Of Portland |
Methods for obtaining taxanes
|
CN1240702C
(zh)
|
2000-09-18 |
2006-02-08 |
威克斯医药有限公司 |
高获得率提取替曲朵辛的方法
|
WO2002024179A2
(en)
*
|
2000-09-22 |
2002-03-28 |
Bristol-Myers Squibb Company |
Method for reducing toxicity of combined chemotherapies
|
CN1187355C
(zh)
|
2000-11-22 |
2005-02-02 |
南宁枫叶药业有限公司 |
精制高纯度替曲朵辛的方法
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
US20030054036A1
(en)
*
|
2001-03-13 |
2003-03-20 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
US20020183266A1
(en)
*
|
2001-03-15 |
2002-12-05 |
Aventis Pharma, S.A. |
Combination comprising combretastatin and anticancer agents
|
ES2387562T3
(es)
*
|
2001-03-23 |
2012-09-26 |
Luitpold Pharmaceuticals, Inc. |
Conjugados alcohol graso-medicamento
|
EP1427407A4
(en)
*
|
2001-03-23 |
2005-05-11 |
Luitpold Pharm Inc |
CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS
|
US6479679B1
(en)
|
2001-04-25 |
2002-11-12 |
Napro Biotherapeutics, Inc. |
Two-step conversion of protected taxane ester to paclitaxel
|
US6452025B1
(en)
|
2001-04-25 |
2002-09-17 |
Napro Biotherapeutics, Inc. |
Three-step conversion of protected taxane ester to paclitaxel
|
IL161372A0
(en)
*
|
2001-11-30 |
2004-09-27 |
Bristol Myers Squibb Co |
Crystalline solvates of paclitaxel
|
US20030216758A1
(en)
*
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
HUE037352T2
(hu)
|
2002-04-05 |
2018-08-28 |
Roche Innovation Ct Copenhagen As |
A HIF-1alfa expresszálódását módosító oligomer vegyületek
|
ATE457716T1
(de)
|
2002-12-30 |
2010-03-15 |
Angiotech Int Ag |
Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
|
US7713738B2
(en)
|
2003-02-10 |
2010-05-11 |
Enzon Pharmaceuticals, Inc. |
Oligomeric compounds for the modulation of survivin expression
|
US6759539B1
(en)
|
2003-02-27 |
2004-07-06 |
Chaichem Pharmaceuticals International |
Process for isolation and purification of paclitaxel from natural sources
|
RU2377301C2
(ru)
|
2003-12-23 |
2009-12-27 |
Сантарис Фарма А/С |
ОЛИГОМЕРНОЕ СОЕДИНЕНИЕ, ПОНИЖАЮЩЕЕ ЭКСПРЕССИЮ ЧЕЛОВЕЧЕСКОГО ГЕНА Bcl-2, КОНЪЮГАТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ПРИМЕНЕНИЕ ОЛИГОМЕРНОГО СОЕДИНЕНИЯ ДЛЯ ЛЕЧЕНИЯ РАКА
|
WO2005077984A1
(ja)
*
|
2004-02-13 |
2005-08-25 |
Osaka Industrial Promotion Organization |
有機化合物の製造方法およびそれに用いる抗体
|
US7846940B2
(en)
*
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7989490B2
(en)
*
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
EP1824975B9
(en)
|
2004-11-09 |
2011-04-20 |
Santaris Pharma A/S |
Lna oligonucleotides and the treatment of cancer
|
CA2587173C
(en)
*
|
2004-11-09 |
2016-09-06 |
Santaris Pharma A/S |
Potent lna oligonucleotides for the inhibition of hif-1a expression
|
US9447138B2
(en)
|
2004-11-09 |
2016-09-20 |
Roche Innovation Center Copenhagen A/S |
Potent LNA oligonucleotides for the inhibition of HIF-1a expression
|
CA2594474C
(en)
|
2005-01-21 |
2016-03-29 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
US20070073385A1
(en)
*
|
2005-09-20 |
2007-03-29 |
Cook Incorporated |
Eluting, implantable medical device
|
PL217731B1
(pl)
|
2006-06-01 |
2014-08-29 |
Tomasz Byrski |
Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi
|
EP2380606B1
(en)
|
2006-06-30 |
2018-03-21 |
Cook Medical Technologies LLC |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
EP2073807A1
(en)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
US20080241215A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Robert Falotico |
Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
|
US20090069410A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched paclitaxel
|
US8409601B2
(en)
*
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8273404B2
(en)
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US9198968B2
(en)
|
2008-09-15 |
2015-12-01 |
The Spectranetics Corporation |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
FR2939665B1
(fr)
|
2008-12-12 |
2011-10-07 |
Sanofi Aventis |
Combinaison antitumorale associant l'ave8062a et le docetaxel
|
MX2013000250A
(es)
|
2010-07-02 |
2013-10-28 |
Angiochem Inc |
Polipeptidos cortos y que contienen d-aminoacido para conjugados terapeuticos y usos de los mismos.
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
PT2753355T
(pt)
|
2011-09-08 |
2019-02-01 |
Univ New York |
Vírus herpes simplex oncolítico e suas utilizações terapêuticas
|
EP2750683B2
(en)
|
2011-10-03 |
2021-01-06 |
Croda International PLC |
Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
|
WO2013096455A1
(en)
|
2011-12-20 |
2013-06-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
CA2874521A1
(en)
|
2012-05-24 |
2013-11-28 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
WO2014014518A1
(en)
|
2012-07-18 |
2014-01-23 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
EP2968406A4
(en)
|
2013-03-14 |
2016-10-26 |
Icahn School Med Mount Sinai |
AUTOLOGOUS TUMOR LYSAT-FILLED DENDRITIC CELL VACCINE FOR THE TREATMENT OF LIVER CANCER
|
WO2014163558A1
(en)
|
2013-04-01 |
2014-10-09 |
Moreinx Ab |
Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
|
US10130590B2
(en)
|
2013-10-01 |
2018-11-20 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
US10350264B2
(en)
|
2014-03-27 |
2019-07-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
WO2016205429A1
(en)
|
2015-06-15 |
2016-12-22 |
New York University |
Method of treatment using oncolytic viruses
|
AU2016326747A1
(en)
|
2015-09-25 |
2018-03-01 |
Zy Therapeutics Inc. |
Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
|
CN109195593A
(zh)
|
2016-03-15 |
2019-01-11 |
奥莱松基因组股份有限公司 |
用于治疗实体瘤的lsd1抑制剂的组合
|
CN109414439A
(zh)
|
2016-06-29 |
2019-03-01 |
伊莱利利公司 |
用于治疗胰腺癌的erk1/2抑制剂化合物与吉西他滨或者与吉西他滨和白蛋白结合型紫杉醇的组合
|
WO2018094275A1
(en)
|
2016-11-18 |
2018-05-24 |
Tolero Pharmaceuticals, Inc. |
Alvocidib prodrugs and their use as protein kinase inhibitors
|
WO2019055579A1
(en)
|
2017-09-12 |
2019-03-21 |
Tolero Pharmaceuticals, Inc. |
TREATMENT REGIME FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 ALVOCIDIB INHIBITOR
|
WO2020117988A1
(en)
|
2018-12-04 |
2020-06-11 |
Tolero Pharmaceuticals, Inc. |
Cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
|
EP3669890A1
(en)
|
2018-12-18 |
2020-06-24 |
Croda International PLC |
Filamentous nanoparticles having vaccine adjuvant effect
|
US11793802B2
(en)
|
2019-03-20 |
2023-10-24 |
Sumitomo Pharma Oncology, Inc. |
Treatment of acute myeloid leukemia (AML) with venetoclax failure
|